CFTR modulators effect on hypoglycemia: CFTR modulators, particularly ivacaftor (IVA), have been shown to improve insulin secretion in PwCF—most notably in those carrying gating mutations such as G551D—suggesting potential restoration of islet function and improved glucose regulation [66, 67]. This evidence concerns the gene INS and Hypoglycemia.